SEC Filings

Filing Description Date Filed Sorted Descending Size  
SC 13D general statement of beneficial ownership Nov 21, 2008 133.8 KB Add to Briefcase
SC 13D general statement of beneficial ownership Nov 20, 2008 75.4 KB Add to Briefcase
SC 13D general statement of beneficial ownership Nov 20, 2008 75.4 KB Add to Briefcase
4 adelman, robert j Nov 18, 2008 22.6 KB Add to Briefcase
4 orbimed, advisors llc Nov 18, 2008 23.8 KB Add to Briefcase
4 mpm, bioventures iii qp lp Nov 17, 2008 27.6 KB Add to Briefcase
4 simon, nicholas j iii Nov 17, 2008 22.3 KB Add to Briefcase
4 gadicke, ansbert Nov 17, 2008 26.0 KB Add to Briefcase
8-K current report Nov 17, 2008 21.4 KB Add to Briefcase
3 kolluri krishna kittu Nov 14, 2008 17.9 KB Add to Briefcase
3 trainor iii eugene a Nov 14, 2008 17.9 KB Add to Briefcase
3 baskett forest Nov 14, 2008 17.9 KB Add to Briefcase
3 drant ryan d Nov 14, 2008 17.9 KB Add to Briefcase
3 kerins patrick j Nov 14, 2008 17.9 KB Add to Briefcase
3 linehan charles m Nov 14, 2008 17.9 KB Add to Briefcase
3 kramlich c richard Nov 14, 2008 21.4 KB Add to Briefcase
10-Q quarterly report Nov 13, 2008 480.6 KB Add to Briefcase
8-K current report Nov 12, 2008 615.2 KB Add to Briefcase
4 druzgala, pascal Oct 28, 2008 23.1 KB Add to Briefcase
8-K current report Oct 23, 2008 193.4 KB Add to Briefcase
Showing 1-20 of 100 Page: 1 2 3 ... 5  Next 20
Add to Briefcase = add filing to Briefcase
Stock Information
NASD:ARYX
$1.50   - 0.04
Nov 21, 2008
4:00 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
 ARYx Therapeutics Final
     Prospectus

Corporate Presentation

Learn more about our products, technology, and financial history by viewing our Corporate Presentation.

Learn More